| scholarly article | Q13442814 |
| P2093 | author name string | Angela Pyle | |
| Gavin Hudson | |||
| Marzena Kurzawa-Akanbi | |||
| Hannah Lowes | |||
| P2860 | cites work | The choroid plexus-cerebrospinal fluid interface in Alzheimer's disease: more than just a barrier | Q26747041 |
| Structure and function of mitochondrial membrane protein complexes | Q26777934 | ||
| A balanced view of choroid plexus structure and function: Focus on adult humans | Q27022103 | ||
| Neuropathological stageing of Alzheimer-related changes | Q27860862 | ||
| Mitochondria Know No Boundaries: Mechanisms and Functions of Intercellular Mitochondrial Transfer | Q28068140 | ||
| Role of neuroinflammation in neurodegenerative diseases (Review) | Q28080292 | ||
| The Roles of Mitochondrial Damage-Associated Molecular Patterns in Diseases | Q28396823 | ||
| Synaptophysin regulates the kinetics of synaptic vesicle endocytosis in central neurons | Q28512527 | ||
| Circulating mitochondrial DAMPs cause inflammatory responses to injury | Q29614470 | ||
| Cerebrospinal fluid mitochondrial DNA: a novel DAMP in pediatric traumatic brain injury | Q33625095 | ||
| A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking. | Q33731693 | ||
| Clinical aspects of palliative care in advanced Parkinson's disease | Q34457767 | ||
| Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry | Q34556945 | ||
| A cell biological perspective on mitochondrial dysfunction in Parkinson disease and other neurodegenerative diseases | Q34628278 | ||
| Accurate measurement of mitochondrial DNA deletion level and copy number differences in human skeletal muscle | Q34634671 | ||
| Plasma DNA concentration as a predictor of mortality and sepsis in critically ill patients | Q34999508 | ||
| Recent advances in our understanding of neurodegeneration | Q34999535 | ||
| Choroid plexus ageing of the brain and Alzheimer s disease | Q35109482 | ||
| Calcium-dependent mitochondrial extrusion in ciliated protozoa | Q35501994 | ||
| Synaptophysin: a marker protein for neuroendocrine cells and neoplasms | Q35606412 | ||
| Mitochondrial DNA Depletion in Respiratory Chain-Deficient Parkinson Disease Neurons. | Q35852144 | ||
| Reduced mitochondrial DNA copy number is a biomarker of Parkinson's disease | Q36595645 | ||
| Somatic mtDNA variation is an important component of Parkinson's disease | Q36595656 | ||
| Level of blood cell-free circulating mitochondrial DNA as a novel biomarker of acute myocardial ischemia | Q59106192 | ||
| Inflammation and neurodegeneration: chronicity matters | Q61446169 | ||
| Cell-Free DNA as a Biomarker in Autoimmune Rheumatic Diseases | Q64075227 | ||
| Cell-free mitochondrial DNA in progressive multiple sclerosis | Q64076159 | ||
| Cell-Free Mitochondrial DNA in the CSF: A Potential Prognostic Biomarker of Anti-NMDAR Encephalitis | Q64243522 | ||
| Kearns-sayre syndrome: oncocytic transformation of choroid plexus epithelium | Q73039001 | ||
| Circulating cell-free mitochondrial DNA levels in Parkinson's disease are influenced by treatment | Q89763645 | ||
| Investigation of mitochondrial biogenesis defects in single substantia nigra neurons using post-mortem human tissues | Q91123919 | ||
| Detection of Cell-Free Mitochondrial DNA in Cerebrospinal Fluid of Creutzfeldt-Jakob Patients | Q91781998 | ||
| Converging pathways in neurodegeneration, from genetics to mechanisms | Q91786464 | ||
| Blood contains circulating cell-free respiratory competent mitochondria | Q92762931 | ||
| Regulation of BDNF-TrkB Signaling and Potential Therapeutic Strategies for Parkinson's Disease | Q92812717 | ||
| Cryo-electron microscopy of extracellular vesicles from cerebrospinal fluid | Q93061661 | ||
| ??? | Q94720111 | ||
| Cell-free mitochondrial DNA in CSF is associated with early viral rebound, inflammation, and severity of neurocognitive deficits in HIV infection | Q36888321 | ||
| Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication | Q36986848 | ||
| Mitochondrial DNA mutations in disease, aging, and neurodegeneration | Q37348532 | ||
| Levels of plasma circulating cell free nuclear and mitochondrial DNA as potential biomarkers for breast tumors. | Q37429524 | ||
| Defective mitochondrial DNA homeostasis in the substantia nigra in Parkinson disease | Q37434427 | ||
| Mitochondrial transcription factor A regulates mitochondrial transcription initiation, DNA packaging, and genome copy number | Q37998804 | ||
| 14-3-3 proteins in neurological disorders. | Q38024792 | ||
| Mitochondrial DNA mutations in neurodegeneration | Q38503652 | ||
| The relationship between circulating mitochondrial DNA and inflammatory cytokines in patients with major depression | Q38716725 | ||
| Diagnostic and prognostic potential of circulating cell-free genomic and mitochondrial DNA fragments in clear cell renal cell carcinoma patients | Q38942565 | ||
| Mitochondrial Dysfunction and Biogenesis in Neurodegenerative diseases: Pathogenesis and Treatment. | Q39016389 | ||
| Plasma Circulating Cell-free Nuclear and Mitochondrial DNA as Potential Biomarkers in the Peripheral Blood of Breast Cancer Patients | Q39204668 | ||
| Extracellular Mitochondria and Mitochondrial Components Act as Damage-Associated Molecular Pattern Molecules in the Mouse Brain | Q39452345 | ||
| Mitochondrial abnormalities in choroid plexus of Leigh disease | Q39641248 | ||
| α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study | Q39783457 | ||
| Direct quantification of CSF alpha-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration | Q40071251 | ||
| Endoscopic ultrasound-guided fine-needle aspirate-derived preclinical pancreatic cancer models reveal panitumumab sensitivity in KRAS wild-type tumors. | Q40332952 | ||
| Increased cell-free mitochondrial DNA is a marker of ongoing inflammation and better neurocognitive function in virologically suppressed HIV-infected individuals | Q40422272 | ||
| Cerebrospinal fluid mitochondrial DNA in the Alzheimer's disease continuum. | Q40435571 | ||
| Reduced cerebrospinal fluid mitochondrial DNA is a biomarker for early-stage Parkinson's disease | Q40568866 | ||
| Circulating cell-free mitochondrial DNA as the probable inducer of early endothelial dysfunction in the prediabetic patient | Q40886964 | ||
| The effects of excitotoxic lesions of the substantia innominata, ventral and dorsal globus pallidus on the acquisition and retention of a conditional visual discrimination: implications for cholinergic hypotheses of learning and memory | Q41464969 | ||
| C. elegans neurons jettison protein aggregates and mitochondria under neurotoxic stress | Q41764579 | ||
| Mitochondrial DNA is released by shock and activates neutrophils via p38 map kinase | Q41937134 | ||
| Erratum to: Mitochondrial DNA point mutations and relative copy number in 1363 disease and control human brains | Q42071897 | ||
| Mitochondrial content of choroid plexus epithelium | Q42447182 | ||
| Innate and adaptive immune responses in neurodegeneration and repair. | Q44581205 | ||
| Protein Biomarkers and Neuroproteomics Characterization of Microvesicles/Exosomes from Human Cerebrospinal Fluid Following Traumatic Brain Injury. | Q46172024 | ||
| Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry | Q47587631 | ||
| Reduced mitochondrial DNA is not a biomarker of depression in Parkinson's disease | Q48038954 | ||
| Elevated levels of cerebrospinal fluid neuron-specific enolase (NSE), but not S100B in major depressive disorder | Q48202410 | ||
| Extracellular Mitochondria in Cerebrospinal Fluid and Neurological Recovery After Subarachnoid Hemorrhage. | Q48218865 | ||
| Protein Characterization of Extracellular Microvesicles/Exosomes Released from Cytotoxin-Challenged Rat Cerebrocortical Mixed Culture and Mouse N2a Cells | Q48268616 | ||
| Cerebrospinal fluid alpha-synuclein in neurodegenerative disorders-a marker of synapse loss? | Q48819771 | ||
| New Insights into the Role of Neuron-Specific Enolase in Neuro-Inflammation, Neurodegeneration, and Neuroprotection | Q49804316 | ||
| Circulating cell-free mitochondrial DNA, but not leukocyte mitochondrial DNA copy number, is elevated in major depressive disorder | Q49912084 | ||
| Low cerebrospinal fluid concentration of mitochondrial DNA in preclinical Alzheimer disease. | Q50489370 | ||
| The diverse origins of circulating cell-free DNA in the human body: a critical re-evaluation of the literature. | Q52719443 | ||
| Increased levels of cell-free mitochondrial DNA in the cerebrospinal fluid of patients with multiple sclerosis. | Q52936351 | ||
| Plasma circulating cell-free mitochondrial DNA in the assessment of Friedreich's ataxia. | Q53095554 | ||
| Circulating Cell Free Mitochondrial DNA is a Biomarker in the Development of Coronary Heart Disease in the Patients with Type 2 Diabetes. | Q53376123 | ||
| Circulating mitochondrial DNA in serum: a universal diagnostic biomarker for patients with urological malignancies. | Q54409514 | ||
| Levels of circulating cell-free nuclear and mitochondrial DNA in benign and malignant ovarian tumors. | Q54513784 | ||
| Free DNA in the serum of cancer patients and the effect of therapy. | Q55492005 | ||
| Diagnostic biomarkers for Parkinson's disease at a glance: where are we? | Q57142239 | ||
| Plasma β-globin DNA as a prognostic marker in chest pain patients | Q57753178 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 15253 | |
| P577 | publication date | 2020-09-17 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Post-mortem ventricular cerebrospinal fluid cell-free-mtDNA in neurodegenerative disease | |
| P478 | volume | 10 |
Search more.